The latest chapter in an ongoing legal battle between Abbott Laboratories and parents of babies born prematurely is slated to ...

Attorneys for parents and Abbott Laboratories faced off during opening arguments Monday in the first Chicago trial over ...

"Boring" may be just what the doctor ordered in this volatile market.

Abbott Laboratories’ modelled fair value has been adjusted only fractionally, from US$133.39 to US$133.33 per share, keeping the core price target effectively stable in absolute terms. That tiny shift ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Abbott Laboratories (NYSE:ABT) is one of Goldman Sachs top healthcare stocks. On March 10, Abbott Laboratories (NYSE:ABT) confirmed the launch of its most advanced generation stent, XIENCE Skypoint, ...

You may not immediately recognize the name Abbott Laboratories (NYSE: ABT), but you've probably come into close contact with one of the company's many products -- from a coronavirus test to Ensure ...

Abbott Laboratories Inc. defeated a proposed class action alleging it disclosed the protected health data of consumers to ...

Abbott Laboratories is scheduled to report fourth-quarter earnings before the market opens Thursday. Here is what you need to know: NET INCOME: The healthcare-products maker is projected to post a ...

If you are wondering whether Abbott Laboratories is offering fair value at around US$112.65 per share, you are not alone. This article is designed to help you make sense of what that price might ...

Shares of Abbott Laboratories ABT shed 1.33% to $109.56 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 1.33% to 6,740.02 and ...

This company has delivered earnings and dividend growth over time. Abbott’s innovation and a new acquisition could spur more growth in the years to come. 10 stocks we like better than Abbott ...